Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2024
Archives
Chronic organ damage: Understanding fibrosis
Fibrosis was once considered irreversible, resulting from chronic organ damage; Ken-Ichi Kobayashi from Notre Dame Seishin University tells us why the possibility of treatment to reverse the disease is gaining attention.
The cellular mechanisms of kidney fibrosis: A hitherto understudies aspect of polycystic kidney disease
In this exclusive Q&A session with Dr. Andras Kapus, we unravel the complexities of chronic kidney disease in general and Polycystic Kidney Disease (PKD) in particular, and delve into the ongoing research efforts aimed at combatting kidney fibrosis.
Wastewater surveillance for infectious disease preparedness
The University of Oklahoma Wastewater Based Epidemiology (OU WBE) team highlights successes from their three years of wastewater surveillance in Oklahoma & how this surveillance approach can be used as next-level monitoring for infectious disease preparedness.
CB₂R ligands to treat inflammatory diseases
Researchers discuss how scientific innovations might influence the discovery of future tailor-made CB2R-based anti-inflammatory treatments.
Post-pandemic MERS-CoV still presents risks
Darryl Falzarano, Research Scientist at the Vaccine and Infectious Disease Organization (VIDO), discusses potential solutions that are needed to tackle the coronavirus known as MERS-CoV.
Combatting NCDs using Plant-based Proteins and Animal-Waste Products
Professor Apichart Vanavichit, PhD, a Rice Genomic Breeding Expert at the Rice Science Center, walks us through high-quality crop-based and ovo-based protein hydrolysates to combat non-communicable diseases in Thailand, specifically among its ageing population.
CB2R agonists in the clinics: A treasure chest for treating inflammatory diseases
Researchers give an update on clinical trials with CB2R agonists and their potential for the treatment of inflammatory diseases.
Microalgae as a sustainable source of protein and food ingredients
Microalgae can be an alternative sustainable source of protein and functional food ingredients that have the potential to improve gut and liver health.
Biocontrol fungi for plant disease research
Susanne Zeilinger, University Professor for Microbiology, underscores sustainable solutions for plant disease research, focusing on the power of biocontrol fungi.
Towards One Health Intelligence surveillance systems
The increase in global diseases and other health threats in recent decades has necessitated the importance of strengthening our surveillance systems towards early detection and monitoring of drivers.
Understanding age-related macular degeneration
Tunde Peto, Professor of Clinical Ophthalmology at Queen’s University Belfast, describes the symptoms, causes and treatments for age-related macular degeneration and how the prevalence of the disease could be reduced.
Classification of rare diseases: The case of the ultra-and hyper-rare
Dr C. I. Edvard Smith, Dr Daniel W. Hagey and Dr Rula Zain, from the Karolinska Institutet in Sweden, note that there is an almost infinite number of unique diseases, contributing to the challenges with the classification of rare diseases.
Applying data science advances in disease surveillance and control
Dr. David S. Ebert from the University of Oklahoma’s Data Institute for Societal Challenges and Dr. Aaron Wendelboe from the University of Oklahoma Health Sciences Center outline how a cohesive, multidisciplinary, and multi-tiered approach can support a more predictive model in disease surveillance and control.
Exploring the possibilities of bacteriophages for tuberculosis
Bacteriophages have long offered prospects for treating bacterial infections. Is it time to use phages to control tuberculosis? Professor Graham F. Hatfull explores this.
The potential of microparticles for active surveillance of infectious diseases
Emmanuel Kifaro from the SACIDS Foundation for One Health, and College of Veterinary Medicine and Biomedical Sciences, Sokoine University of Agriculture, Tanzania, details the potential application of microparticles for active surveillance of viral infections from non-invasive animal matrices.
RNA molecule signature diagnosis could revolutionize personalized medicine
Professor Michael Levin from Imperial College London argues that in the DIAMONDS project, there has been a breakthrough response in personalized medicine via RNA molecular signature diagnosis.
HIV therapeutic targets: Basic virology to the discovery of antiretroviral drugs
Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.
Can we produce new medicines from microalgae?
Inflammatory bowel disease (IBD) is a chronic inflammation in the digestive tract. Currently no effective treatment exists, something that the researchers of the EU-funded Algae4IBD project want to change with the help of microalgae.
Visualizing the anti-inflammatory cannabinoid Type-2 receptor
Medicinal chemists describe how small molecule probes allow for the detection of CB2R, and thereby enable the discovery of novel anti-inflammatory treatments.
Allergic asthma and the legacy of structural racism on the African American urban communities
Allergic asthma is a chronic inflammatory disease characterized by bronchial hyperactivity, disproportionately affecting African Americans.
